SCHEMBL2361098

SCHEMBL2361098

CCCCCNC(=O)Nc1ccccn1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.91
SMN1; SMN2 Q16637 2/20 0.91
ALOX12 P18054 1/20 0.75
EPHX1 P07099 4/20 0.60
ALDH1A1 P00352 1/20 0.60
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
EPHX2 P34913 1/20 0.54
GAA P10253 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
PIM1 P11309 1/20 0.53
ADORA2A P29274 1/20 0.53
ADORA2B P29275 1/20 0.53
ADORA1 P30542 1/20 0.53
FLT3 P36888 1/20 0.53
PIM3 Q86V86 1/20 0.53
AURKB Q96GD4 1/20 0.53
ATM Q13315 1/20 0.52
PKM P14618 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10985519 0.89 SMN1; SMN2 (0.83) HTTSMN1; SMN2ALOX12ALDH1A1NPC1
SCHEMBL10757398 0.87 HTT (0.70) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1
SCHEMBL10852491 0.87 HTT (0.70) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1
SCHEMBL8590214 0.86 ALOX12 (1.00) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1
SCHEMBL8473735 0.85 HTT (0.67) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1
SCHEMBL12410301 0.83 SMN1; SMN2 (0.72) HTTSMN1; SMN2ALOX12NPC1RAB9A
SCHEMBL13411171 0.82 SMN1; SMN2 (0.71) HTTSMN1; SMN2ALOX12ALDH1A1NPC1
SCHEMBL10853481 0.82 SMN1; SMN2 (0.76) HTTSMN1; SMN2ALOX12NPC1RAB9A
SCHEMBL10756833 0.82 HTT (0.76) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1
SCHEMBL2828548 0.82 ALOX12 (0.67) HTTSMN1; SMN2ALOX12EPHX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379507-B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS BAYER HEALTHCARE LLC (US) 2011-08-17 EP disclosed